
### [Orphanet:100094](http://www.orpha.net/ORDO/Orphanet_100094)
**Label:** Multiple polyglandular tumor

**Subclasses:** [Orphanet:892](http://www.orpha.net/ORDO/Orphanet_892) (Von Hippel-Lindau disease), [Orphanet:276152](http://www.orpha.net/ORDO/Orphanet_276152) (Multiple endocrine neoplasia type 4), [Orphanet:139411](http://www.orpha.net/ORDO/Orphanet_139411) (Carney triad), [Orphanet:1359](http://www.orpha.net/ORDO/Orphanet_1359) (Carney complex), [Orphanet:97286](http://www.orpha.net/ORDO/Orphanet_97286) (Carney-Stratakis syndrome), 

**Corr. equiv. classes:** [Orphanet:892](http://www.orpha.net/ORDO/Orphanet_892), [OMIM:160980](http://purl.obolibrary.org/obo/OMIM_160980), [Orphanet:139411](http://www.orpha.net/ORDO/Orphanet_139411), [Orphanet:97286](http://www.orpha.net/ORDO/Orphanet_97286), [OMIM:606864](http://purl.obolibrary.org/obo/OMIM_606864), [OMIM:193300](http://purl.obolibrary.org/obo/OMIM_193300), [OMIM:610755](http://purl.obolibrary.org/obo/OMIM_610755), [OMIM:605244](http://purl.obolibrary.org/obo/OMIM_605244), [OMIM:604287](http://purl.obolibrary.org/obo/OMIM_604287), [Orphanet:1359](http://www.orpha.net/ORDO/Orphanet_1359), [Orphanet:276152](http://www.orpha.net/ORDO/Orphanet_276152), 

**Class expressions from DL-Learner:**

- [HP:0100634](http://purl.obolibrary.org/obo/HP_0100634) (Neuroendocrine neoplasm) 71.53%
- [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) and [HP:0002668](http://purl.obolibrary.org/obo/HP_0002668) (Paraganglioma) 63.64%
- [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) and [HP:0002668](http://purl.obolibrary.org/obo/HP_0002668) (Paraganglioma) and [HP:0025031](http://purl.obolibrary.org/obo/HP_0025031) (Abnormality of the digestive system) 63.64%
- [HP:0002668](http://purl.obolibrary.org/obo/HP_0002668) (Paraganglioma) and [HP:0025031](http://purl.obolibrary.org/obo/HP_0025031) (Abnormality of the digestive system) 62.90%
- [HP:0002668](http://purl.obolibrary.org/obo/HP_0002668) (Paraganglioma) and [HP:0011024](http://purl.obolibrary.org/obo/HP_0011024) (Abnormality of the gastrointestinal tract) 56.94%
- [HP:0002668](http://purl.obolibrary.org/obo/HP_0002668) (Paraganglioma) and [HP:0007378](http://purl.obolibrary.org/obo/HP_0007378) (Neoplasm of the gastrointestinal tract) 56.94%
- [HP:0002668](http://purl.obolibrary.org/obo/HP_0002668) (Paraganglioma) and [HP:0011025](http://purl.obolibrary.org/obo/HP_0011025) (Abnormality of cardiovascular system physiology) and [HP:0025031](http://purl.obolibrary.org/obo/HP_0025031) (Abnormality of the digestive system) 56.94%
- [HP:0001626](http://purl.obolibrary.org/obo/HP_0001626) (Abnormality of the cardiovascular system) and [HP:0002668](http://purl.obolibrary.org/obo/HP_0002668) (Paraganglioma) and [HP:0025031](http://purl.obolibrary.org/obo/HP_0025031) (Abnormality of the digestive system) 56.94%
- [HP:0002666](http://purl.obolibrary.org/obo/HP_0002666) (Pheochromocytoma) 52.61%
- [HP:0002668](http://purl.obolibrary.org/obo/HP_0002668) (Paraganglioma) 51.52%
- [HP:0002668](http://purl.obolibrary.org/obo/HP_0002668) (Paraganglioma) and [HP:0011025](http://purl.obolibrary.org/obo/HP_0011025) (Abnormality of cardiovascular system physiology) 48.99%
- [HP:0001626](http://purl.obolibrary.org/obo/HP_0001626) (Abnormality of the cardiovascular system) and [HP:0002668](http://purl.obolibrary.org/obo/HP_0002668) (Paraganglioma) 48.99%
- [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) 46.52%
- [HP:0000818](http://purl.obolibrary.org/obo/HP_0000818) (Abnormality of the endocrine system) 45.66%
- [HP:0000707](http://purl.obolibrary.org/obo/HP_0000707) (Abnormality of the nervous system) 43.19%


